Assessing safety of eating before cerebral angiography
Verification of the Safety of Normal Food Before a Cerebral Arteriography
This study is testing if it's safe for adults to eat breakfast before having a cerebral angiography and whether it causes nausea or vomiting.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Trial ID | NCT04477031 on ClinicalTrials.gov |
What this trial studies
This observational study evaluates the safety of allowing patients to eat breakfast before undergoing elective cerebral angiography. It aims to determine the frequency of nausea and vomiting in patients who do not fast prior to the procedure. The hypothesis is that less than 1% of non-fasting patients will experience vomiting, challenging the current fasting requirements. The study will involve adult patients undergoing day care hospitalization for the procedure.
Who should consider this trial
Good fit: Ideal candidates are adults scheduled for elective cerebral angiography who are not fasting.
Not a fit: Patients who are children, pregnant, or have conditions such as nausea or vomiting prior to the procedure will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to changes in pre-procedure fasting guidelines, improving patient comfort and reducing unnecessary fasting.
How similar studies have performed: While there is limited data on this specific approach, similar studies have questioned fasting protocols in various medical procedures, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult, * non fasting, * day care hosptilalisation Exclusion Criteria: * Childs, * pregnancy, * parenteral nutrition, * nausea, * vomiting before arteriography, * arteriography under general anesthesia
Where this trial is running
Nantes
- CHU de Nantes — Nantes, France (Recruiting)
Study contacts
- Principal investigator: Benjamin Daumas-Duport, ph — Nantes University Hospital
- Study coordinator: Benjamin Daumas-Duport, ph
- Email: benjamin.daumasduport@chu-nantes.fr
- Phone: 02.40.16.56.11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.